Search

Author/Creator Bogart, Jeffrey

1. A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer. Issue 1 (January 2015)

Authors:
Lilenbaum, Rogerio; Samuels, Michael; Wang, Xiaofei; Kong, Feng Ming; Jänne, Pasi A.; Masters, Gregory; Katragadda, Sreedhar; Hodgson, Lydia; Bogart, Jeffrey; Bradley, Jeffrey; Vokes, Everett
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG). Issue 1 (January 2015)

Authors:
Lilenbaum, Rogerio; Samuels, Michael; Wang, Xiaofei; Kong, Feng Ming; Jänne, Pasi A.; Masters, Gregory; Katragadda, Sreedhar; Hodgson, Lydia; Bogart, Jeffrey; Bradley, Jeffrey; Vokes, Everett
Journal:
Journal of thoracic oncology
Issue:
Volume 10:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Positron Emission Tomography–Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance). Issue 5 (10th February 2023)

Authors:
LaCasce, Ann S.; Dockter, Travis; Ruppert, Amy S.; Kostakoglu, Lale; Schöder, Heiko; Hsi, Eric; Bogart, Jeffrey; Cheson, Bruce; Wagner-Johnston, Nina; Abramson, Jeremy; Blum, Kristie; Leonard, John P.; Bartlett, Nancy L.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 5(2023)
Page Start:
1023
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Issue 2 (February 2015)

Authors:
Bradley, Jeffrey D; Paulus, Rebecca; Komaki, Ritsuko; Masters, Gregory; Blumenschein, George; Schild, Steven; Bogart, Jeffrey; Hu, Chen; Forster, Kenneth; Magliocco, Anthony; Kavadi, Vivek; Garces, Yolanda I; Narayan, Samir; Iyengar, Puneeth; Robinson, Cliff; Wynn, Raymond B; Koprowski, Christoph...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Issue 2 (February 2015)

Authors:
Bradley, Jeffrey D; Paulus, Rebecca; Komaki, Ritsuko; Masters, Gregory; Blumenschein, George; Schild, Steven; Bogart, Jeffrey; Hu, Chen; Forster, Kenneth; Magliocco, Anthony; Kavadi, Vivek; Garces, Yolanda I; Narayan, Samir; Iyengar, Puneeth; Robinson, Cliff; Wynn, Raymond B; Koprowski, Christoph...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer. (September 2021)

Authors:
Kozono, David E.; Stinchcombe, Thomas E.; Salama, Joseph K.; Bogart, Jeffrey; Petty, W. Jeffrey; Guarino, Michael J.; Bazhenova, Lyudmila; Larner, James M.; Weiss, Jared; DiPetrillo, Thomas A.; Feigenberg, Steven J.; Chen, Xin; Sun, Zhaowen; Nuthalapati, Silpa; Rosenwinkel, Lindsey; Johnson, Eric...
Journal:
Lung cancer
Issue:
Volume 159(2021)
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗